Resource impact statement

No resource impact is anticipated

We do not expect this guidance to have an overall impact on resources.

Initially there may be costs in primary care from longer appointments, optimising treatments and care, and associated training. However, this is expected to be offset by savings from better and more streamlined management of multimorbidity, from fewer unnecessary appointments, fewer medicines prescribed and fewer unplanned hospital admissions.

The commissioners affected by this guideline are clinical commissioning groups (CCGs) and NHS England. Providers affected are primary care services and NHS hospital trusts.

This page was last updated: 21 September 2016